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Abstract
Background: There appears to be an obvious gap between a medical and patient adherence perspective.
Deviating from a medication prescription could be regarded as fairly irrational, but with respect to patients’ goals
and/or concerns it could be seen as understandable. Thus, the aim was to elucidate adherence reasoning in
relation to asthma medication.
Methods: This was a qualitative study; data collection and analysis procedures were conducted according to
Grounded Theory methodology. Eighteen persons, aged 22 with asthma and regular asthma medication treatment,
were interviewed.
Results: The emerged theoretical model illustrated that adherence to asthma medication was motivated by three
foci, all directed towards a desired outcome in terms of a functional day as desired by the patient. A promotive focus
was associated with the ambition to achieve a positive asthma outcome by being adherent either to the received
prescription or to a self-adjusted dosage. A preventive focus was intended to ensure avoidance of a negative
asthma outcome either by sticking to the prescription or by preventively overusing the medication. A permissive
focus was associated with unstructured adherence behaviour in which medication intake was primarily triggered by
asthma symptoms.
Conclusions: As all participants had consciously adopted functioning medication tactics that directed them
towards the desired goal of a functional day. In an effort to bridge the gap between a patient- and a medical
adherence perspective, patients need support in defining their desired functionality and guidance in developing a
person-based medication tactic.
Background
A novel trend direction in health care has been estab-
lished in recent years. It is seen in the transition from
disease-oriented care [1] to a more patient-centred
approach [2], which is intended to result in a shared
decision about treatment between the patient and the
caregiver [1]. It has been argued that a patient-centred
approach is crucial for encouraging adherence to treat-
ment [3]. With reference to asthma medication treat-
ment, several studies have reported figures showing
lower adherence than prescribed [4-8]. From a medical
perspective, deviating from a medication prescription
could seem rather irrational, because it could constitute
the missing link between a prescribed treatment and an
efficacious outcome [9]. Inadequate adherence to asthma
medication can be traced to poor asthma outcome
[10,11] and more frequent health-care seeking [12], with
increasing health-care costs as a consequence [13].
From a patient perspective, deviating from a pre-
scribed treatment could seem rational; for instance, reg-
ular medication intake is incongruent with denial of an
asthma diagnosis or with the belief that asthma is an
acute illness [14]. Patients’ perception of asthma seems
to influence adherence behaviour, as those who do not
experience any symptoms [15] or start to feel better
when medication is initiated tend to deliberately inter-
rupt the medication treatment [16]. By contrast, patients
who perceive their asthma as severe [15] or subjectively
experience symptom relief [16] are more likely to adhere
to prescribed asthma medication [15,16]. The conviction
that the best way to prevent asthma symptoms from
occurring is to combat asthma triggers, such as infection
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or stress, tends to be associated with a preference for
alternative treatment methods [17]. Beliefs about medi-
cation are known to play a significant role for adherence
behaviour. Patients who regard the asthma medication
as a necessity for their health are more likely to follow
their prescriptions [15,18,19], unlike those who are con-
cerned with side effects or are afraid of becoming
dependent [18,19].
From a psychological perspective, there are indications
that personality traits influence medication adherence
[20-26]. From an integrative personality perspective, per-
sonality traits in conjunction with human nature, cul-
ture, life narratives and characteristic adaptation need to
be considered if we are to understand the individual as
a whole. Characteristic adaptation refers to how indivi-
duals tackle everyday life and speaks to the motives,
goals, plans and so forth that can be explained by cogni-
tive-motivational strategies [27]. As such, Higgins’s the-
ory of self-regulatory focus as a motivational principle
[28] explains individual differences in goal-directed
behaviour in terms of two distinct systems: promotion
and prevention. Although both systems are directed
towards the same goal, they operate somewhat differ-
ently. The promotion system focuses on the achieve-
ment of a positive outcome, while the prevention system
focuses on the avoidance of a negative outcome [28].
The present study was conducted to gain a broader
and deeper understanding of adherence behaviour in
young adults by studying it in light of personal charac-
teristic adaptation. Thus, the aim was to elucidate
adherence reasoning in relation to asthma medication.
Methods
To get a broader picture of adherence behaviour, a qua-
litative design was used in which data were derived
from interviews. The sampling and analysis procedures
were carried out in accordance with Grounded Theory
(GT), as described by Strauss and Corbin [29]. Episte-
mologically, this version of GT is situated between the
classic version, which is more positivistic in nature, and
the constructivist or post-modern version [30].
Study participants
The participants (n = 18) were sampled from an epide-
miological study of young adults with asthma born
between 1985 and 1987, who had been prescribed regu-
lar asthma medication and who had completed an
adherence questionnaire [20]. A purposive sampling
procedure [31] was applied, resulting in recruitment of
participants with various reported adherence scores [20].
Characteristics of the participants are shown in Table 1.
The eligible participants were invited to take part by tel-
ephone. Both verbal and written information were pro-
vided, with an emphasis on voluntary participation.
Data collection
Data were collected through interviews, during which
the participants were asked to speak as freely as possible
about their adherence behaviour. Prior to the interview,
each participant’s informed consent was obtained. The
interviews lasted on average 45 minutes, were recorded
digitally and transcribed verbatim.
Rigour
An important consideration in GT is the balance
between theoretical sensitivity [29] and the interaction
Table 1 Characteristics of the participants
n
Age






















Emergency visit, the last 12 months
Yes 2
No 16







* = Combined inhaler (Single inhaler combining corticosteriods and long-
acting beta-2 agonist (LABA))
# = Inhaled corticosteriods (ICS), Short-acting beta-2 agonist (SABA)
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between the researcher and the data, which is termed
reflexivity [32,33]. This delicate matter was dealt with by
maintaining constant responsiveness throughout the
data collection and analysis. Ideas arising from the ana-
lysis were reconfirmed during subsequent collection of
new data. Non-confirmed ideas could thereby be dis-
carded. This handling of the data is in line with what in
the GT tradition is referred to as constant comparison
[29]. In addition, comparisons with literature on adher-
ence and health behaviour were conducted to stimulate
thinking during the examination of properties and
dimensions in the current data. To maintain a sceptical
stance, formulated concepts and categories were vali-
dated in subsequent interviews. Occasionally, the data
were kept at a distance for a period of time, which
allowed the researchers to return to them with a critical
eye, ready to judge whether the provisional theory still
fitted the data [29].
Analysis
The sampling procedure was carried out hand-in-hand
with the analysis of interview data, in accordance with
GT [29]. The computer-based program NVivo was used
to handle and organize the data [34]. The initial inter-
views began in a rather unprejudiced fashion with an
open-ended question about medication intake that was
followed by probing questions. This was a way for the
researchers to keep their minds open to the diversity of
incidents and to minimize the risk of forcing the inter-
view in a given direction. Gradually, the interviews
became more systematic so as to enable comparisons
with the ideas emerging from the analysis. The inter-
viewer still strived for a flexible stance to permit new
events and directions in the interviews. Directly after an
interview, a memo was written in order to document the
interviewer’s instant impression of the collected data.
The interviews were transcribed verbatim as soon as pos-
sible, and the analysis followed. The analysis procedure
was a constant comparison of data as regards similarities
and differences, with a focus on ongoing processes that
started with a microanalysis close to the data. During this
phase, the data were examined by asking “How? What?
Why?” questions. This part of the analysis generated
codes that, depending on their content, were organized
into preliminary categories and labelled based on con-
tents of meaning. As an example, several codes contained
different motives for the young adult’s adherence beha-
viour such as “hoping for well-being” and “avoiding a
risk”. These formed a preliminary category named “hav-
ing a motive for adherence behaviour”. During the ensu-
ing interviews, the preliminary categories were tested as
regards dimensions and properties to enable the building
of more solid categories. The subsequent analysis contin-
ued by selecting the categories of significance in relation
to the aim, and the properties of these categories were
defined. This so-called focused coding disclosed an
obvious variation in adherence motives that deserved a
proper explanation. To stimulate the creative thinking
needed during this phase, appropriate literature was used
as a cache for inspiration [29]. By coincidence, the
researchers found [35] Higgins’s theory of self-regulatory
focus as a motivational principle [28], which comprises
two systems: prevention and promotion foci. These were
the parts in the category thus far labelled “having a
motive for adherence behaviour” that had been over-
looked and lacking. At this point, three more refined
categories labelled “promotive focus” and “preventive
focus” were developed. The third category, “permissive
focus”, could perhaps be seen as an extension of Higgins’s
theory [28], because it was based on data that did not fit
into that theory. The following axial coding produced
subcategories such as “approaching illness control”. Early
in the analysis process, the researchers got the impres-
sion that “illness control” seemed to be fundamental to
adherence behaviour. The theoretical sampling was then
concentrated on discovering aspects of this concept. The
interview questions were more directed at defining and
specifying the importance of experienced illness control
in relation to adherence. Already collected data were
returned to in order to see if this association could be
observed, and if so, to reorganize the data. Concurrent
with the sampling and the writing of analysis memos, dia-
grams of relationships between categories were drawn.
Eventually, a core category emerged - “A functional day
as desired by the person” - to which the other categories
could be related. A theoretical model grounded in the
collected interview data illustrating adherence behaviour
in young adults with asthma was then constructed (Fig-
ure 1).
The Ethical considerations
Ethical approval was granted by the Regional Ethical
Review Board at the University of Gothenburg in 2006
(reg. no. 486-06). The participants received both verbal
and written information about the aim and utility of the
study. They were further told about confidentiality, that
their participation was voluntary and that they could with-
draw from the study at any time without stating a reason.
Results
The core category “A functional day as desired by the per-
son” was described as having a normal life, which included
expectations of being able to manage anything a person
without asthma could. Various examples were given, such
as physical activities both in terms of exercise and daily
activities like climbing the stairs or running for a bus, but
also being able to burst into laughter without experiencing
symptoms. In brief, an everyday life in which the asthma
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did not show its face. Most of them reported having
achieved a desired functional day. However, it was evident
that some of the participants experienced restrictions in
relation to certain physical activities, yet they perceived
their everyday life with asthma as satisfactory. This percep-
tion could be explained by the comparisons they made
between today’s asthma function and previous function
during childhood, when the asthma was experienced as
much severer. A functional day seemed to regulate efforts
to achieve this outcome.
As illustrated in Figure 1, three types of regulatory foci
were identified: Promotive, Preventive and Permissive,
which regulated three types of medication tactics:
Approaching illness control, Avoiding uncontrolled ill-
ness and Acting on the spur of symptoms.
Promotive focus
This focus was characterized by an eagerness to strive
for a positive asthma outcome. This thinking stemmed
from a strong wish to live a life equal to that of persons
without asthma. Participants associated with this focus
aspired to accomplish all of the important things in life
without being disturbed by the asthma. Therefore a pro-
motive focus was aimed at progressing with the medica-
tion tactic to attain a functional day.
Asthma playing in the background
When the asthma was playing in the background, no
signs of illness were present in everyday life. The asthma
did not interfere with activities in daily life, which
allowed the participants to do things that played an
important role in their social life. Another advantage of
having asthma in control was the possibility to manage
other daily activities without experiencing restrictions.
“It means that I, for example, have the energy to climb
the stairs much more easily than I would without medi-
cation. Without standing and panting afterwards and
feeling the tightness and all. Or when I run to the bus
when I’m about to miss it. Things like that.” (4)
A functional day –
as desired by the person
PREVENTIVE
FOCUS










Figure 1 A theoretical model illustrating adherence behaviour in young adults with asthma.
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Approaching controlled illness
Promotive adherence reasoning
This reasoning was influenced by the aspiration to
achieve a functional day. Adhering to the asthma medi-
cation prescription was thus viewed as advancement
towards this ideal state when the asthma only plays in
the background. Some medication worries were put for-
ward, but the benefits seemed to exceed the concerns. It
was argued that this medication tactic was considered
promising because it was expected to promote a pre-
ferred lifestyle.
“You want to do exercise, for example, because that’s
important for your body. So you get to take a little medi-
cine so you can manage it. Anyway it’s a good reason to
take medicine. It’s great. So then you take it to feel
good.” (7)
Participants who had adopted this type of adherence
behaviour had noted that it generated a positive out-
come reflected in an asthma day that was easily mana-
ged. When they had found themselves between
prescriptions, they had experienced episodes during
which the desired outcome had not been attained. Such
experiences were used as opportunities to compare peri-
ods when the asthma was playing in the background
with periods when the asthma was showing its face.
Eventually, these experiences seemed to function as evi-
dence of the gains associated with their present medica-
tion tactic.
“It’s because I know it makes me feel better. I have
tested, for example, when I’ve run out of medicine and
not received the new prescription yet. So I’ve been with-
out it a while and I simply notice the difference in how I
feel. So that’s why I’m careful with it, because I know I
feel better and that everyday life is easier for me. Well,
that’s the simple reason.” (4)
Promotive medication adjustment
This medication tactic was aimed at achieving a desired
asthma outcome by using a minimum of asthma medi-
cation. Thus, medication use was adjusted depending on
estimated need without jeopardizing a positive outcome.
One advantage of this strategy was that the body was
not exposed to medication unnecessarily, while no clear
concerns about side effects were expressed. This tactic
rested on the opinion that every person knows best how
his/her own body functions - even better than the doc-
tors who made their assessment during a short clinical
visit, sometimes without performing medical tests. This
thinking led to medication breaks of varying duration.
Some had been off medication for almost a year, but
were still able achieve a functional day. Others had
shorter breaks, for instance during stays abroad for a
couple of weeks to several months when the asthma was
perceived to function satisfactorily without medication.
“So I don’t really follow the doctor’s orders to the letter,
instead I have a feeling for what’s needed. And if I’m just
.... going on a trip for two weeks then I don’t need to take
it just because I’m travelling.” (14)
Shorter breaks during periods requiring less physical
exertion also occurred. It was stressed that this strategy
was not recommended for persons newly diagnosed
with asthma, because it required experience. It was also
expressed that one risk associated with this strategy is
that one could unconsciously get used to poorer asthma
function.
Preventive focus
This focus was grounded in a sense of responsibility one
had to oneself to be spared from a situation in which
the asthma dominated everyday life. Participants asso-
ciated with this focus tended to act in an anticipatory
way to keep the signs of illness away. This thinking was
shown in their adherence behaviour, which was moti-
vated by the need to ensure that asthma would not play
in the foreground.
Asthma playing in the foreground
When the asthma played in the foreground, it showed
its face as typical asthma symptoms. These episodes var-
ied in length and severity, but were perceived as a direct
consequence of not having taken the asthma medication
as usual.
“Then my voice gets hoarse. It can be a little tough
when I wake up, sometimes breast pain when I breath
and I feel ... so I lose my voice often and at times it’s
hard to talk and I’m clearing my voice all the time,
that’s what happens. I don’t feel quite as alert either.” (1)
It was not only the occurrence of symptoms that was
experienced as troublesome when the asthma set the
agenda, but also its effect on daily life as a whole. Such
a period was described as being characterized by poor
strength and difficulty managing ordinary physical activ-
ities like climbing the stairs. An insufficient ability to
stay focused that negatively affected their work or stu-
dies was also described.
Avoiding uncontrolled illness
Preventive adherence reasoning
This medication tactic was aimed at avoiding being con-
trolled by the asthma. Simultaneously, it was expected
to secure a functional day. Taking the asthma medica-
tion as recommended was therefore considered both as
a necessary investment and as an essential tactic.
Despite a few concerns with intake of asthma medica-
tion, this medication tactic was regarded as a precau-
tionary measure that was believed to prevent the asthma
from playing in the foreground, both at present and in
the future.
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“... I take them because I know I won’t feel well if I
don’t take them. So somewhere in the back of my mind
there’s something saying I have to take them in order to
get through the day.” (15)
“It may get worse in the future ... if I don’t take my
medicine now, I probably won’t feel good in the future,
and I think about that.” (1)
It was also argued that this tactic had spared them
from severe asthma attacks in the past. Some partici-
pants had experienced troublesome asthma attacks that
had etched fearful memories in their minds. These were
incidents they never wanted to relive again. Some even
expressed worries about not currently having a sufficient
medication treatment, despite claiming to experience a
functional day. Others knew about other people’s
asthma mismanagement and concomitant severe attacks.
Thus, taken together, these experiences functioned as
cautionary examples that influenced their current adher-
ence behaviour.
It was explained that managing asthma through pre-
ventive adherence behaviour had an overall advantage in
terms of the sense of calm that grows out of being cer-
tain one is safe.
“Well, then it’s like you take it to feel ... feel secure and
protected. You don’t have to feel bad as often.” (11)
Preventive medication overuse
Another preventive medication tactic was to overuse the
asthma medication. This tactic seemed to be associated
with distrust that the current prescription of asthma
medication provided comprehensive protection from a
negative asthma outcome. Preventive overuse was delib-
erately put into practice as an additional guarantee that
the asthma would have no opportunity to play in the
foreground. In these cases, the asthma was considered a
very troublesome disease and a watchful eye was con-
stantly kept on possible emerging asthma symptoms.
This tactic was manifested by taking both the preventive
and reliever asthma medication more times a day than
was prescribed.
“I’m supposed to take my preventer inhaler daily,
morning and evening, but sometimes I take it several
times a day. Along with my rescue inhaler.” (8)
Yet another type of preventive overuse was described
that only involved the reliever medication. It was
regarded as a required preventive measure to make sure
that the asthma would not play in the foreground, for
example when performing strenuous physical activities.
The experience of side effects such as tremor and palpi-
tations was thought to be a worthwhile investment
given the benefit of this protective medication tactic.
Permissive focus
This focus was aligned with a kind of “let-it-go” mental-
ity, according to which everything will turn out fine.
Some skeptical voices towards intake of asthma medica-
tion were raised, but they were not heard in general.
Participants associated with this way of thinking gave
the expression of being rather indifferent in relation to
asthma and its outcome. Despite the fact that they had
experienced severe attacks, they acted as if their every-
day life was seemingly unaffected by asthma. They
vaguely described a desired asthma outcome as being
relieved from emerging symptoms.
Asthma playing out of earshot
The asthma was explained as something that was
included in the participants’ daily life and that they did
not pay much attention to. One good reason was that
asthma was given low priority due to another, more
troublesome disease. Another was that the accuracy of
the asthma diagnosis was doubted. It was argued that
asthma symptoms could just as well be experienced by
all people, even those without an asthma diagnosis.
There was an obvious paradox in these lines of reason-
ing, as being completely without asthma medication was
not an option.
“Of course I want the rescue inhaler - I don’t want to
get rid of that. ... ... but maybe even people in general
sometimes have trouble breathing ... I don’t know what’s
normal.” (10)
Acting on the spur of symptoms
Permissive adherence reasoning
This medication tactic was justified by the explanation
that the participants’ asthma mostly was playing out of
earshot. However, when the symptoms became more
pronounced, they triggered the intake of asthma medica-
tion. Although these participants described their medi-
cation tactic as not recommendable, they seemed
unmotivated to change tactics. No benefit of this medi-
cation tactic was expressed. Instead it was put forward
that regular medication behaviour would be more
advantageous. Still, they reported not really wanting to
change their medication tactics.
“I don’t think I’ll change anything, I’ll just keep doing
what I do now or .... although it would probably be good
to develop a routine for this. But I don’t think I’ll do
anything about it.” (13)
Unstructured medication use
sParticipants associated with a permissive focus had no
integrated routines for their medication intake. They
seldom prepared themselves before contact with
known asthma triggers, meaning that they did not act
until the asthma was playing within earshot. Conse-
quently, they reported unstructured adherence beha-
viour, implying that the asthma medication was not
taken regularly.
“No, it feels like it’s been a long time since I was good
at taking the preventer inhaler so I really don’t know.
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No, I don’t know. I’m really bad about taking my medi-
cations, that’s all.” (10)
Sometimes the medication was taken according to
prescription, then it was not taken at all for a few weeks
or even longer periods. Still the asthma function was
experienced as satisfactory, on the whole.
Discussion
The present findings demonstrated that adherence beha-
viour in relation to regular asthma medication treatment
was grounded in conscious reasoning strongly influ-
enced by a desire to have a functional day. Three foci
regulated participants’ adherence behaviour, as illu-
strated in the emergent theoretical model (Figure 1). A
promotive focus contained an ambition to achieve con-
trolled illness, which inspired two types of medication
tactics: promotive adherence reasoning and promotive
medication adjustment. A preventive focus was seen as
ensuring avoidance of uncontrolled illness and led to
preventive adherence reasoning and preventive medica-
tion overuse. A permissive focus led to permissive adher-
ence reasoning and unstructured adherence behaviour,
where asthma symptoms triggered medication intake.
Several methods exist for assessing adherence, but in a
clinical setting questioning is a common method [9].
There are indications that accurately determining the
level of a patient’s adherence could be a difficult task in
the context of a clinical meeting [36-40]. Looking at the
adherence reasoning among the participants, it became
clear that they did not speak of adherence as a quantita-
tive measure or a certain adherence level. Instead, their
main priority in taking asthma medication was to have
a functional day. On their way to this desired state, they
were guided by the three motivational foci, which led to
different medication tactics. This indicates that having a
goal for one’s adherence behaviour is of greater signifi-
cance to the patient than adhering or not adhering to a
prescribed dosage.
The study shows that all participants had consciously
adopted a functioning medication tactic that served
their needs. From a medical perspective, the presented
adherence behaviour probably leaves much to be
desired. To arrive at a “win-win adherence outcome”,
the gap between a patient and medical adherence per-
spective needs to be bridged, which requires a mutual
effort between the patient and the health-care personnel.
Patient-centred care stipulates a cooperative effort
intended to bring about the best possible health out-
come. Health-care personnel are supposed to respect
patients’ needs and preferences, but also to empower
patients to make informed health choices. Patients’
responsibility is to actively participate in care and to
strive for a better health outcome, which includes adher-
ence to treatment [41].
With regard to the current findings, identifying what a
functional day means to the patient could be a good
starting point to jointly find a proper medication tactic
and to bridge the gap between the two perspectives.
Methodological considerations
The reason for conducting this study by using a qualita-
tive method was the nature of the study’s aim. The GT
methodology offers an inductive strategy for collecting
and analyzing qualitative data that ends in a theoretical
model grounded in data. This method led the research-
ers to a novel understanding of adherence behaviour in
young adults with asthma by exploring their thought
processes and reasoning about their medication intake.
The theoretical model explaining adherence behaviour
was built through a systematic and an analytic research
process and therefore has explanatory power for the
sample from which the data was collected. When sam-
pling for a qualitative study the focus is not on the
representativeness of the population in the same way as
in a quantitative method but on the representativeness
and variation of the concepts. In the current study, we
focused on the indicatives of adherence behaviour to
saturate the categories not on the number of intervie-
wees as one interview can give several aspects of the
phenomenon under investigation. The theoretical model
was not validated statistically because it according to
GT methodology was validated throughout the research
process by constant comparison of data [29]. This does
not rule out that the model could be tested statistically
in future studies in samples designed for statistical
methods.
Possible limitations of the current study are that the
participants were homogenous as regards age and that
they had lived most of their lives with asthma. This
homogeneity could also be the strength of the study, as
the findings are based on rather long lived experience of
having asthma. No data on asthma severity were col-
lected, which could be a weakness because degree of
severity may influence adherence behaviour. The
emerged theoretical model was grounded in data derived
from a specific context in terms of a sample consisting
of young adults and compared to a quantitative study
based on a small sample size, which in fact is a common
procedure in qualitative research. For these reasons, the
findings may not be transferable to other groups with
asthma, which indeed is an indication of the need for
further studies.
A potential strength of the current study is that it can
add another previously neglected variable to the concept
of phenotypes. By definition, the term “phenotype”
includes an organism’s behaviour, but in current studies
of phenotypes of asthma, behaviour and personality are
not attended to. Thus, until now, the term phenotype in
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relation to asthma has included “observable characteris-
tics of asthma such as physiology, triggers, inflammation
and response to medication treatment” [42] but has
ignored behaviour. For example, the patient’s behaviour,
including adherence to prescribed medication, can
change the degree of expression of disease and may
influence severity of asthma. Therefore, the currently
described concept showing that three different foci of
different asthmatic individuals regulated different kinds
of adherence behaviour, will have vast impact on the
expression of disease. All three foci are directed towards
one desired goal: a functional day as desired by the per-
son. Thus, participants associated with a promotive focus
were active in achieving a mild phenotype and partici-
pants associated with a preventive focus were active in
avoiding a severe phenotype. In contrast, participants
associated with a permissive focus seemed more likely to
act on the asthma syndrome i.e. the symptoms, allowing
for a more severe phenotype at some occasions. There-
fore, behavioural aspects should be carefully assessed in
describing asthma phenotypes, and future development
of questionnaires identifying patients with different foci
could help in this regard.
Conclusions
As all participants had consciously adopted functioning
medication tactics that directed them towards the
desired goal of a functional day. As an effort to bridge
the gap between a patient and a medical adherence per-
spective, patients need support from health-care person-
nel in defining their desired functional day and guidance
in achieving an appropriate medication tactic.
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